Bacteria · Species

Faecalibacterium prausnitzii

Beneficial   A dominant butyrate producer with strong anti-inflammatory effects — one of the most consistently health-associated bacteria in the gut.

Associated with these conditions

Depletion of this anti-inflammatory butyrate producer is among the most consistently replicated IBD findings.

Well-replicated

Butyrate producers decline — but several studies were confounded by metformin, not diabetes itself.

Moderate evidence studies conflict

Protective butyrate producers tend to be depleted as tumors develop.

Moderate evidence

Lower abundance correlates with depression and reduced quality-of-life scores in population studies.

Moderate evidence
Psoriasis Reduced

Depletion of this anti-inflammatory species is reported in psoriasis cohorts.

Preliminary
Asthma Reduced

Part of the protective FLVR taxa whose early depletion tracks asthma risk.

Moderate evidence
Atopy Associated with

Reported in Disbiome.

Preliminary
Obesity Associated with

Reported in Disbiome.

Preliminary
Hepatitis B Associated with

Reported in Disbiome.

Preliminary
Cirrhosis Associated with

Reported in Disbiome.

Preliminary
Keratitis Associated with

Reported in Disbiome.

Preliminary
Frailty Associated with

Reported in Disbiome.

Preliminary
Cholestasis Associated with

Reported in Disbiome.

Preliminary
Migraine Associated with

Reported in Disbiome.

Preliminary
Lung cancer Associated with

Reported in Disbiome.

Preliminary
Fatigue Associated with

Reported in Disbiome.

Preliminary
Covid-19 Associated with

Reported in Disbiome.

Preliminary
What shifts it
Helps make
‹ All organisms